Position in NVAX
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,959
+$266 QoQ
Shares Held
208
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 89 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hilltop National Bank holds $486,936 across 11 Biotechnology names. NVAX ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
2,163 | $152,815 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
303 | $150,508 | |
| 3 | INCY |
Incyte Corp
|
550 | $62,348 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
201 | $48,434 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
900 | $28,287 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
116 | $21,724 | |
| 7 | INSM |
INSMED Inc
|
187 | $19,937 | |
| 8 | NVAX |
Novavax Inc
This page
|
208 | $1,959 |
All Filings in NVAX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,959 | 208 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1,693 | 208 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $1,397 | 208 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,803 | 208 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $1,310 | 208 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $281 | 35 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $442 | 35 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $443 | 35 | Shares | Defined | 2024-07-10 | |
| 2024-03-31 | $167 | 35 | Shares | Defined | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||